A Randomized, Open-label, Multicenter, Phase 3 Study to...

  • Main
  • 2017 / 07
  • A Randomized, Open-label, Multicenter, Phase 3 Study to...
Annals of Oncology 2017 / 07

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin to Treatment of Physician’s Choice in Patients With Advanced Non−Small Cell Lung Cancer

Katakami, N., Felip, E., Spigel, D. R., Kim, J-H., Olivo, M., Guo, M., Nokihara, H., Yang, J. C-H., Iannotti, N., Satouchi, M., Barlesi, F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx284
Date:
July, 2017
File:
PDF, 737 KB
english, 2017
Conversion to is in progress
Conversion to is failed